2,3,5-Triphenyl-2H-tetrazolium chloride Cas:298-96-4 98% Off-white/pale yellow crystalline powder
Catalog Number | XD90154 |
Product Name | 2,3,5-Triphenyl-2H-tetrazolium chloride |
CAS | 298-96-4 |
Molecular Formula | C19H15N4·Cl |
Molecular Weight | 334.80 |
Storage Details | 2 kusvika ku8 °C |
Harmonised Tariff Code | 29339980 |
Chigadzirwa Specification
Chitarisiko | Off-white/pale yellow crystalline powder |
Assay | Min.98% |
Melting Point | 235 - 245 Deg C |
Kurasika paKuomesa | <3.0% |
Mvura Yemukati | 0.5% Max |
Residue paIgnition | Max.0.5% |
Solubility muEtoH | Pass |
Solubility muEthanol | Zvakajeka uye zvakakwana |
Kuti uongorore kunobatsira kwekubatanidzwa kwebutyrate, Lactobacillus casei, uye L-carnitine mumuenzaniso we rat colitis.Makonzo akakamurwa kuva mapoka manomwe.Mapoka mana akagamuchira oral butyrate, L-carnitine, Lactobacillus casei uye kusanganiswa kwevatatu vamiririri kwemazuva gumi akatevedzana.Mapoka akasara aisanganisira zvidzoreso zvisina kunaka uye zvakanaka uye boka resham.Macroscopic, histopathological examinations, uye biomarkers senge tumor necrosis factor-alpha (TNF-α) uye interlukin-1β (IL-1β), myeloperoxidase (MPO), thiobarbituric acid reactive substances (TBARS), uye ferric inoderedza kukwanisa kweplasma (FRAP) ) zvakatemerwa mucolon.Kurapa kwekubatanidza kwakaratidza chinhu chakakosha chinobatsira mukuderedza colitis kana ichienzaniswa nekutonga.Kuchinja kwese mukuderedzwa kweTNF-α (114.66 ± 18.26 vs 171.78 ± 9.48 pg/mg protein, P <0.05), IL-1β (24.9 ± 1.07 vs 33.06 ± 2.16 pg/mg protein, P2), TBARS. ± 0.03 vs 0.49 ± 0.04 μg/mg protein, P <0.01), MPO (15.32 ± 0.4 vs 27.24 ± 3.84 U/mg protein, P <0.05), uye kukwirira kweFRAP (23.46 ± 1.3 μ2/7 vs , P <0.05) tsigira kudiwa kwemusanganiswa kurapa mukuenzanisa nekutonga.Kunyange zvazvo monotherapies yaibatsirawo mukuvandudza zviratidzo zvecolitis, kurapa kwemusanganiswa kwaive nani mukuvandudza kwecolon oxidative stress markers zvinosanganisira FRAP, TBARS, uye MPO. mamiriro ekiriniki.